[36:54] Dr
Compounded medications are prepared for an individual patient and are not FDA-approved
However, in general, it can be concluded that in most cases and independently of their physicochemical characteristics, IONPs promote an M1 phenotype in macrophages, both in tumor and non-tumor tissues, even in the presence of a pro-M2 stimulus such as IL-4 (157)
Common reasons include low glutathione concentration, unstable liposomes, tablet compression destroying liposomal structure, and sub-therapeutic dosing
78 In fact, the authors of a review that mentioned this study noted it was not overly informative and reliable due to those limitations
There is not yet reliable clinical-trial evidence showing that BPC-157 heals tendon, ligament or muscle injuries in people